Pure Global
NCT00420173

Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)

Interdisciplinary Study Group of Lupus Erythematosus
European Society of Cutaneous Lupus Erythematosus e.V.·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cutaneous Lupus Erythematosus
Drug/Device/Intervention
Laboratory analysis
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
European Society of Cutaneous Lupus Erythematosus e.V.
Location
Muenster, Germany
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2004
End date
Jun 01, 2008
Enrollment
45 participants
Summary

Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical
 manifestations and a variable prognosis. The aim of this study is to create a standardized
 evaluation of the different subtypes of this disease in order to receive an overview of the
 spectrum of clinical and laboratory features as well as the therapeutic strategies for
 patients with CLE.

ICD-10 classifications
Subacute cutaneous lupus erythematosusLupus erythematosusDiscoid lupus erythematosusSystemic lupus erythematosusSystemic lupus erythematosus, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT00420173
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT00420173 through Pure Global AI's free database. This phase not specified trial is sponsored by European Society of Cutaneous Lupus Erythematosus e.V. and is currently Completed. The study focuses on Cutaneous Lupus Erythematosus. Target enrollment is 45 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.